drugset / Trial / NCT02131298

Effect Of Itraconazole On The Pharmacokinetics Of Palbociclib

NCT02131298

Phase 1 Completed 12 enrolled Pfizer
CrossoverOpen-labelBasic science

Summary

This study is designed to evaluate the potential effect of itraconazole on the pharmacokinetics of palbociclib.

Timeline

Start
2014-05
Primary completion
2014-06
Completion
2014-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Itraconazole Small molecule 200 mg
Subject Palbociclib Small molecule 125 mg Oral

Indications

No indication recorded.